SCHEMBL740955

SCHEMBL740955

CC(C)(NC(=O)c1cc2c(NC(=O)c3cccnc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK7 P50613 3/20 0.48
AURKA O14965 1/20 0.48
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
MAPK1 P28482 1/20 0.45
MAPT P10636 1/20 0.44
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CCNA1 P78396 1/20 0.42
IMPDH2 P12268 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
KCNK3 O14649 1/20 0.41
PRKAB2 O43741 1/20 0.41
PRKAG1 P54619 1/20 0.41
PRKAA2 P54646 1/20 0.41
PRKAA1 Q13131 1/20 0.41
PRKAG3 Q9UGI9 1/20 0.41
PRKAG2 Q9UGJ0 1/20 0.41
PRKAB1 Q9Y478 1/20 0.41
USP36 Q9P275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740292 0.91 AURKA (0.55) CDK7AURKAABL1BCRCCNA2
SCHEMBL740809 0.90 AURKA (0.52) CDK7AURKAABL1BCRMAPK1
SCHEMBL1779700 0.85 AURKA (0.50) AURKAABL1BCRMAPTKDM4E
SCHEMBL742124 0.85 AURKA (0.48) CDK7AURKAABL1BCRMAPK1
SCHEMBL741311 0.85 AURKA (0.53) CDK7AURKAABL1BCRMAPT
SCHEMBL738866 0.85 AURKA (0.53) CDK7AURKAABL1BCRMAPT
SCHEMBL741044 0.84 AURKA (0.51) CDK7AURKAABL1BCRIMPDH2
SCHEMBL4631709 0.84 CDK7 (0.54) CDK7MAPK1MAPTSMN1; SMN2KCNK3
SCHEMBL742071 0.84 AURKA (0.46) AURKAABL1BCRMAPK1MAPT
SCHEMBL740599 0.84 AURKA (0.49) CDK7AURKAABL1BCRCCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed